Bioimpedance Analyzers Market Research Report Information by Type (Multi-Frequency, Single-Frequency, And Dual-Frequency) by Modality (Wired Bioimpedance and Wireless Bioimpedance), by Application (Whole-Body Measurement and Segmental Body Measurement), by End User (Hospitals, Fitness Clubs and Wellness Centers, Home Users, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2030

Bioimpedance Analyzers Market Overview

The Bioimpedance Analyzers Market size was valued at USD 0.37 billion in 2022 and is projected to grow from USD 0.41 Billion in 2023 to USD 0.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.50% during the forecast period (2023 - 2030). The increasing prevalence of lifestyle diseases, technological advancements, and initiatives by governments and private organizations to promote healthy lifestyles drive market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Bioimpedance Analyzers Market Trends

• 
  

  The increasing prevalence of lifestyle diseases to boost the market growth

  
  

The prevalence of lifestyle problems is on the rise, which has an impact on the market's growth. Fast food consumption rising, sedentary work conditions becoming more prevalent, and mobility automation increasing are just a few examples of unhealthy lifestyles that could result from a shift in the current quality of living. As a result, lifestyle disorders including diabetes, obesity, and high blood pressure are becoming more common.

Furthermore, according to the WHO, 55–60% of people are predicted to be obese by 2030, making obesity a global pandemic. Obesity is an issue outside of industrialized nations in middle- and low-income countries as well. But obesity is now seen as a worldwide epidemic. In addition, as per the Organization for Economic Co-Operation and Development (OECD) analysis, obesity, and related diseases will reduce life expectancy by about three years across the OECD, European Union 28, and the Group of Twenty (G20) between 2020 to 2050.  Therefore, these factors may encourage the use of the bioimpedance analyzer due to the growing demand for accurate measurement of the muscle, bone, and fat in the human body, which would in turn drive the market growth for bioimpedance analyzers.

Diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation. Diabetes can be treated, and its consequences are avoided or delayed with diet, physical activity, medication, and regular screening and treatment for complications. Moreover, in 2019, diabetes was the direct cause of 1.5 million deaths and 48% of all deaths due to diabetes occurred before the age of 70 years.

According to information provided by the Diabetes Federation (IDF) in 2021, 537 million people aged 20 to 79 had diabetes worldwide by 2021. Moreover, by the year 2050, there will also be 783 million instances of diabetes worldwide. The standardized birth incidence of Gaucher's disease in the general population ranges from 0.39 to 5.80 per 100,000 people each year. Additionally, it is predicted that the demand for bioimpedance analyzers will increase as disease management techniques become more efficient, which would increase the prevalence of metabolic disorders and spur market growth.

Figure 1: Estimated number of people with diabetes (in millions), By Region, 2021-2045

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Bioimpedance Analyzers Market Segment Insights

Bioimpedance Analyzers Type Insights

The market segments of Bioimpedance Analyzers, based on service type, includes multi-frequency, single-frequency, and dual-frequency. The multi-frequency segment held the majority share in 2022 in the Bioimpedance Analyzers Market revenue. This is due to the preference for multi-frequency bioimpedance analyzers is high among end-users as they can be utilized for both segmental and whole-body measurement, far from the single frequency bioimpedance analyzers. Furthermore, these devices are also compact and lightweight, making it simple for households to use them to monitor everyone in the family's health, which is helping the market expand globally.

January 2020 InBody (South Korea) introduced the InBody 970 device. The device utilizes novel technology to categorize and analyze abdominal fat and total body water. The InBody 970 offers a thorough study of abdominal fat, including information on visceral, subcutaneous, and circumference measurements.

Bioimpedance Analyzers Modality Insights

The Bioimpedance Analyzers Market segmentation is based on a modality that includes wired bioimpedance and wireless bioimpedance. the wireless bioimpedance segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2030. The main drivers of this segment's growth are the development of wireless technologies and the rising demand for them. In addition, a Wireless Bioimpedance Device (WBID) detects the electrical resistance of tissues or liquids. Moreover, these devices can be used to gauge heart rate, blood flow, and other physiological aspects in both people and animals.

Figure 2: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY2022 & 2030 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Bioimpedance Analyzers Application Insights

The Bioimpedance Analyzers Market segmentation is based on the application that includes, whole-body measurement and segmental body measurement. The segmental body measurement segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2030. The large share of this segment can be attributed to the rising prevalence of obesity and metabolic disorders. Additionally, segmental bioimpedance analysis can be used to precisely assess the physical and chemical makeup of retail slices of lamb. The shoulder was the most representative cut, while all those evaluated by SBIA were helpful in estimating the components of the edible portion of lamb carcasses.

Bioimpedance Analyzers End User Insights

The Market segmentation of Bioimpedance Analyzers is based on end-user that includes hospitals, fitness clubs and wellness centers, home users, and others. The fitness clubs and wellness centers segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2030. This is due to the increasing number of fitness clubs and wellness centers and the growing awareness about health and fitness across the globe. Moreover, the number of wellness centers and fitness centers has significantly increased over the past few decades, which has led to a greater emphasis on health and fitness among the general population and, in turn, aided the segment expansion.

July 2020 Omron Corporation (Japan) partnered with Mount Sinai Health System (US) of to provide patients with its new VitalSight home blood pressure monitoring solution and to support the needs of their patients with hypertension.

Bioimpedance Analyzers Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North American bioimpedance analyzers market was accounted for the largest market share in 2022. This is attributed to the rising obesity rates, rising healthcare costs, growth in the number of fitness centers and health clubs, as well as a rising older population. For instance, according to the 2020 Profile of Older Americans published by the Administration for Community Living in May 2021, around 54.1 million people in the US were above the age of 65 years. The numbers were projected to rise to 80.8 million in 2040 and 94.7 million by 2060. Therefore, rising healthcare expenditures among the populace are predicted to raise the use of technologically advanced bioimpedance analyzing items in the region for measuring people's body measurements to maintain their health during the course of the projected period.

Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: BIOIMPEDANCE ANALYZERS MARKET SHARE BY REGION 2022 & 2030

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe bioimpedance analyzers market is expected to account for the second-largest market share in 2022. This is due to the rising prevalence of metabolic disorders, increasing government initiatives to encourage the adoption of healthy lifestyles, and rising technological advancements in the region. Further, the Germany market of bioimpedance analyzers was attributed to hold the largest market share the UK market of bioimpedance analyzers is expected to fastest-growing market in the European region.

The Asia-Pacific bioimpedance analyzers are expected to grow at a significant share from 2023 to 2030. This is due to the rising R&D activity and the development of emerging economies like China and India, the region offers lucrative opportunities for players in the market of bioimpedance analyzers. Moreover, China market of bioimpedance analyzers is expected to hold the largest market share, and Japan market of bioimpedance analyzers is expected fastest-growing market in the Asia-Pacific region.

China is a significant market in this regard because of its recent infrastructure development, strong economic growth, rising local demand, and public-private partnerships to finance healthcare research. Moreover, China's State Council approved the 2016–2020 National Fitness Plan, which encouraged overall national fitness and increased sports participation, which will increase the demand for the market of bioimpedance analyzers.

The Rest of the World includes the Middle East, Africa, and Latin America. Nevertheless, due to a lack of awareness and low income, particularly in Africa, the Middle East and Africa held the smallest proportion of the market of bioimpedance analyzers.

Bioimpedance Analyzers Key Market Players & Competitive Insights

The Bioimpedance Analyzers Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists,pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reached across the globe with diverse product portfolios. Companies such as Bioparhom (France), Akern (Italy), Biodynamics Corporation (US), and Tanita Corporation (Japan) dominate the Bioimpedance Analyzers Market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

One of the primary business strategies adopted by manufacturers in the global bioimpedance analyzers industry to benefit clients and expand the market of bioimpedance analyzers sector is to manufacture locally to reduce operating costs.

Akern (Italy), manufactures medical devices and is a medical research company. The company offers solutions such as Clinic and Prevention, Nutrition, Sports and Fitness, Data Analysis software bioimpedance analyzers, and more. For instance, In September 2020, Akern (Italy) launched the BIA101 BIVA PRO analyzer. BIA 101 BIVA PRO is the new bioimpedance analyzer for evaluating nutritional, muscular, and hydro electrolytic status with BIA/BIVA technology.

Also, Bioparhom (France) is engaged in designing, manufacturing, and marketing medical devices for body composition analysis. Its goal is to provide the most accurate measurement and diagnostic tools for body composition data to academics, veterinarians, and professionals in the fields of health, nutrition, and sports (tissues, fluids, and metabolism). The company has a strong presence in France.

Key Companies in the Bioimpedance Analyzers Market include

• Bioparhom (France)


• Akern (Italy)


• Omron Corporation (Japan)


• Biodynamics Corporation (US)


• Tanita Corporation (Japan)


• Biotekna (Italy)


• InBody (South Korea)


• EVOLT 360 (Australia)


• RJL Systems (US)


• Fook Tin Group Holding Ltd (China)

Bioimpedance Analyzers Industry Developments

August 2018 RJL Systems (US) introduced Quantum Legacy, a new affordable BIA instrument that has the same BIA specification as our Quantum IV. It replaces the 20-year-old Quantum II and X and is multilingual (English, Spanish, German, French, and Italian).

April 2022 InBody (South Korea) introduced BWA 2.0 body water analyzer. This new professional-grade device expands upon the outputs measured by the InBody S10 to provide users with more detailed insights that demonstrate how variations in body composition and body water can affect well-being.

September 2019 EVOLT 360 (Australia) launched Mobile App to Track Fitness. Evolt Active App provides easy access for body scan users to their personalized body composition information, which includes a full analysis of muscle and fat percentages as well as nutritional recommendations for optimal health and fitness results.

April 2021 InBody (South Korea) Releases New BP 170 Consumer Blood Pressure Device. The BP 170 is a clinically validated automatic blood pressure monitor that can be used to stay on the pulse of your cardiovascular health.

Bioimpedance Analyzers Market Segmentation

Bioimpedance Analyzers Type Outlook

• Multi-Frequency


• Single-Frequency


• Dual-Frequency

Bioimpedance Analyzers Modality Outlook

• Wired Bioimpedance


• Wireless Bioimpedance

Bioimpedance Analyzers Application Outlook

• Whole-Body Measurement


• Segmental Body Measurement

Bioimpedance Analyzers End User Outlook

• Hospitals


• Fitness Clubs and Wellness Centers


• Home Users


• Others

Bioimpedance Analyzers Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America